India Sun vows ‘appropriate action’ as merger halted (via AFP)
India’s Sun Pharma said Saturday it will take “appropriate action” after a court suspended the generic giant’s $3.2-billion takeover of troubled rival Ranbaxy while insider trading allegations are probed. The Andhra Pradesh High Court order, dated April…
Support InfoStride News' Credible Journalism: Only credible journalism can guarantee a fair, accountable and transparent society, including democracy and government. It involves a lot of efforts and money. We need your support. Click here to Donate